These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis. Meyrick Thomas RH, Rademaker M, Grimes SM, MacKay A, Kovacs IB, Cook ED, Bowcock SM, Kirby JD. Br J Dermatol; 1987 Aug 14; 117(2):237-41. PubMed ID: 3307894 [Abstract] [Full Text] [Related]
18. A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon. Corbin DO, Wood DA, Macintyre CC, Housley E. Eur Heart J; 1986 Feb 14; 7(2):165-70. PubMed ID: 3516704 [Abstract] [Full Text] [Related]
19. A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon. Rhedda A, McCans J, Willan AR, Ford PM. J Rheumatol; 1985 Aug 14; 12(4):724-7. PubMed ID: 3903157 [Abstract] [Full Text] [Related]
20. [Capillaroscopic evaluation of the effects of nifedipine in patients with Raynaud's phenomenon]. Riccio A, Pennarola R, Farinaro C, Scherillo G, Infranzi E, Del Puente A, Oriente P. Clin Ter; 1988 May 15; 125(3):185-90. PubMed ID: 2973939 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]